NNeurology3/26/2026

Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache

This clinical trial provides Class I evidence that eptinezumab with patient education is superior to placebo with patient education in reducing MMDs in adults with CM and MOH.